Abstract | OBJECTIVES: MATERIALS AND METHODS: The experiments were performed on male rats divided into four groups: group 1, control (standart diet); group 2, diabetic control (single dose of 65mg/kg of streptozotocin (STZ), i.p); group 3, STZ+insulin (8IU/kg/day s.c.); group 4 (STZ+l-NAME 5mg/kg/day orally). RESULT:
Streptozotocin-induced diabetic rats, showed a significant increase in blood glucose and serum cholesterol (C) and triglyceride (TG). Compared to the control group with diabetic group plasma LCAT concentrations and erythrocyte membrane Na(+)/K(+) ATPase were found to be decreased. Activities of Na(+)/K(+) ATPase and serum NO level were decreased with the administration of l-NAME. We observed that insulin was ameliorated in all parameters. CONCLUSIONS: Serum NO levels is related to erythrocyte membrane Na(+)/K(+) ATPase activity. But serum NO levels did not affect the plasma LCAT activity and serum lipid profiles.
|
Authors | Neslihan Tekin, Fahrettin Akyüz, Halide Edip Temel |
Journal | Diabetes & metabolic syndrome
(Diabetes Metab Syndr)
2011 Oct-Dec
Vol. 5
Issue 4
Pg. 191-5
ISSN: 1878-0334 [Electronic] Netherlands |
PMID | 25572761
(Publication Type: Journal Article)
|
Copyright | Copyright © 2010 Diabetes India. Published by Elsevier Ltd. All rights reserved. |
Chemical References |
- Blood Glucose
- Enzyme Inhibitors
- Hypoglycemic Agents
- Insulin
- Lipids
- Nitric Oxide
- Phosphatidylcholine-Sterol O-Acyltransferase
- Sodium-Potassium-Exchanging ATPase
- NG-Nitroarginine Methyl Ester
|
Topics |
- Animals
- Blood Glucose
(metabolism)
- Cell Membrane
(enzymology)
- Diabetes Mellitus, Experimental
(blood, drug therapy, pathology)
- Enzyme Inhibitors
(pharmacology)
- Hypoglycemic Agents
(pharmacology)
- Insulin
(pharmacology)
- Lipids
(blood)
- Male
- NG-Nitroarginine Methyl Ester
(pharmacology)
- Nitric Oxide
(blood)
- Phosphatidylcholine-Sterol O-Acyltransferase
(blood)
- Rats
- Rats, Wistar
- Sodium-Potassium-Exchanging ATPase
(blood)
|